Of course, we cannot exclude that in late phases of AD, when they invade the CP, insoluble forms of tau disrupt the functionality of CP epithelial cells, and particularly the synthesis of TTR, thus promoting Aβ peptide aggregation. The gene discussed is MAPT; the disease is Alzheimer disease.